Brian Belmontes

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies

Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 419 citations · Full text

Medicine, Oncology, Pharmacology +14

Effect of AMG 479 on anti-tumor effects of gemcitabine and erlotinib against pancreatic carcinoma xenograft models

Pedro J. Beltran, Patricia L. Mitchell, Gordon Moody et al. · Journal of Clinical Oncology · 2008 · 235 citations

Medicine, Oncology, Pharmacology +16

AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

Pedro J. Beltran, Petia Mitchell, Young-A Chung et al. · Molecular Cancer Therapeutics · 2009 · 131 citations · Full text

Medicine, Oncology, Pharmacology +14

Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors

Brian Belmontes, Deepali V. Sawant, Wendy Zhong et al. · Science Translational Medicine · 2021 · 116 citations

Life Sciences, Immunology, Oncology +17

Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade

Achim K. Moesta, Keegan S. Cooke, Julia Piasecki et al. · Clinical Cancer Research · 2017 · 105 citations

Life Sciences, Immunology, Oncology +17